Company / PP&E per Share
Crinetics Pharmaceuticals, Inc. PP&E per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.15
FY2025
5-year range
$0.06 / $0.19
FY2021-FY2025
Trend
+15.2%
vs FY2024
Sector context
#91 of 191
Health Care
What the data says
At $0.15, Crinetics Pharmaceuticals, Inc.'s pp&e per share ranks #91 of 191 in the Health Care sector. PP&E per Share has fluctuated over the past 9 years, ranging from $0.06 in FY2021 to $164.00 in FY2019.
Based on SEC 10-K filings.
0.15 in FY2025 with a 5-year CAGR of +2.7%.
Declined from $0.19 to $0.15 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +32.0%
- 5-Year CAGR
- +2.7%
- 10-Year CAGR
- -
Sector benchmark
#91 of 191 in Health CareTop 48% of 191This company $0.15 Sector average $22.34
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 15.2% year-over-year.
- Ranks #91 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
- Lowest pp&e per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.15 | +15.2% |
| FY2024 | $0.13 | -30.7% |
| FY2023 | $0.19 | +188.4% |
| FY2022 | $0.06 | +9.5% |
| FY2021 | $0.06 | -54.7% |
| FY2020 | $0.13 | -99.9% |
| FY2019 | $164.00 | +5905.0% |
| FY2018 | $2.73 | +836.1% |
| FY2017 | $0.29 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026